Veterinary Medicines

Alpramil 12.5 mg/125 mg tablets for dogs weighing at least 5 kg

Authorised
  • Praziquantel
  • Milbemycin oxime
Download as PDF

Product identification

Medicine name:
Alpramil 12.5 mg/125 mg tablets for dogs weighing at least 5 kg
Alpramil 12,5 mg/125 mg tabletta legalább 5 kg testtömegű kutyáknak
Active substance:
  • Praziquantel
  • Milbemycin oxime
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    125.00
    milligram(s)
    /
    1.00
    Tablet
  • Milbemycin oxime
    12.50
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB51
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:
  • Box with 10 OPA/Aluminium/PVC-Aluminium blisters each containing 1 tablet.
  • Box with 1 OPA/Aluminium/PVC-Aluminium blister containing 4 tablets.
  • Box with 25 OPA/Aluminium/PVC-Aluminium blisters each containing 4 tablets.
  • Box with 25 OPA/Aluminium/PVC-Aluminium blisters each containing 2 tablets.
  • Box with 25 OPA/Aluminium/PVC-Aluminium blisters each containing 1 tablet.
  • Box with 10 OPA/Aluminium/PVC-Aluminium blisters each containing 4 tablets.
  • Box with 10 OPA/Aluminium/PVC-Aluminium blisters each containing 2 tablets.
  • Box with 1 OPA/Aluminium/PVC-Aluminium blister containing 2 tablets
  • Box with 1 OPA/Aluminium/PVC-Aluminium blister containing 1 tablet

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
  • Lelypharma B.V.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
  • 4326/X/22 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0364/005
Concerned member states:
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."